Clinical Trial Update: Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of hydroxyurea in children and young adults with sickle cell disease and pulmonary hypertension was terminated; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Sickle Cell Disease, Pulmonary Hypertension | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-05-08